AtriCure Inc (NAS:ATRC)
$ 28.28 -0.18 (-0.63%) Market Cap: 1.43 Bil Enterprise Value: 1.36 Bil PE Ratio: 0 PB Ratio: 2.91 GF Score: 76/100

AtriCure Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 06:30PM GMT
Release Date Price: $37.37 (+2.66%)
Lilia;Celine Lozada
JPMorgan Chase & Co - Analyst

Hi, everyone. Thanks for joining. I'm Lily Lozada. I'm on the med tech team here at JPMorgan. Very happy to have the AtriCure team with us here today. CEO, Mike Carrel, is going to do a presentation for us and then we'll jump into some Q&A.

Michael Carrel
AtriCure Inc - President, Chief Executive Officer, Director

Great. Thank you, everyone. I'm Mike Carrel, President and CEO of AtriCure, and thank you to JPMorgan once again and as always for inviting us and having us as a part of this day, the event of JPMorgan in San Francisco. So I'm going to talk about AtriCure. This is --. It's not going forward. I was just -- let's see.

There we go. All right. I got to work out with my thumb a little bit more, I think, and then --. My goal today is to, hopefully, give you a really good overview of the opportunity that we have at AtriCure. Our dedication and focus is to patients at the end of the day, and it's dedicated to reducing the burden of Afib globally and pain after surgery. And,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot